Harmony Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$418K Sell
3,252
-275
-8% -$32.2K 0.11% 141
2026
Q1
$424K Buy
3,527
+1,606
+84% +$185K 0.13% 131
2025
Q4
$202K Buy
+1,921
New +$180K 0.07% 179
2025
Q3
Sell
-4,301
Closed -$340K 175
2025
Q2
$340K Hold
4,301
0.13% 129
2025
Q1
$386K Sell
4,301
-525
-11% -$49K 0.16% 118
2024
Q4
$480K Sell
4,826
-2,716
-36% -$280K 0.19% 101
2024
Q3
$856K Sell
7,542
-5,574
-42% -$662K 0.31% 68
2024
Q2
$1.62M Sell
13,116
-5,060
-28% -$652K 0.68% 41
2024
Q1
$2.4M Hold
18,176
0.99% 33
2023
Q4
$1.98M Buy
+18,176
New +$1.89M 0.84% 41

Other funds holding MRK

Harmony Asset Management's MRK Position: Q2 2026 in Review

Harmony Asset Management reduced its Merck (MRK) stake by 7.8% in Q2 2026, selling an estimated $32.2K and leaving 3,252 shares worth $418K. The position accounts for 0.11% of the portfolio, ranked #141.

Harmony Asset Management first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.4M in Q1 2024. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Harmony Asset Management held 3,252 shares of Merck worth $418K as of Q2 2026.
  • Harmony Asset Management sold 275 Merck shares in Q2 2026, an estimated $32.2K.
  • Merck made up 0.11% of Harmony Asset Management's portfolio in Q2 2026, its #141 holding.
  • Harmony Asset Management first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • Harmony Asset Management's Merck position peaked at $2.4M in Q1 2024.
  • 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Harmony Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.